Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GILEAD SCIENCES Latest News

JAN 30, 2015 - TheStreet

A Must Read - Share

Is the 'January Effect' Signaling a Down Year for the Stock Market?

NEW YORK (TheStreet) -- One adage on Wall Street is, "As goes January, so goes the year." That, however, didn't happen last year and hasn't worked in five of the previous six times when stocks fell in January, Dan Greenhaus, chief global strategist at BTIG Research, said on CNBC's "Fast Money Halftime" TV show on Friday. Must Read: 10 Stocks ...

Tags: Is the 'January Effect' Signaling a Down Year for the Stock Market?,  Gilead Sciences Latest News

JAN 27, 2015 - Wall Street Journal

A Must Read - Share

Gilead to Allow Drug Makers to Produce Hepatitis C Treatment

Gilead Sciences said it would allow generic-drug makers to produce a new version of its Sovaldi hepatitis C treatment.

Tags: Gilead to Allow Drug Makers to Produce Hepatitis C Treatment,  Gilead Sciences Latest News

JAN 21, 2015 - Benzinga

A Must Read - Share

Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences

Deutsche Bank commented on AbbVie Inc (NYSE: ABBV) and Gilead Sciences, Inc. (NASDAQ: GILD) Wednesday and felt that consensus may be too high on both companies. Latest Ratings for ABBV DateFirmActionFromTo Jan 2015BarclaysMaintainsOverweight Jan 2015JefferiesMaintainsBuy Jan 2015Bank of AmericaDowngradesBuyNeutral View More Analyst Ratings for ABBV View the Latest Analyst Ratings

Tags: Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences,  Gilead Sciences Latest News

JAN 20, 2015 - TheStreet

A Must Read - Share

8 Biotech Stock Controversies Emerging From 'JPM15' Conference

BOSTON (TheStreet) -- The biotech sector typically outperforms the broader market during the week of the much-heralded J.P. Morgan Healthcare Conference. This year was no exception. Last week, the Nasdaq Biotechnology Index rose 1.4% compared with a 1.2% loss for the S&P 500. The J.P. Morgan conference is now in the rear-view mirror. But issues, controversies and questions raised during ...

Tags: 8 Biotech Stock Controversies Emerging From 'JPM15' Conference,  Gilead Sciences Latest News

JAN 16, 2015 - ABC News

A Must Read - Share